MED10
Mediator of RNA polymerase II transcription subunit 10
Also known as: L6, MED10_HUMAN, MGC5309, NUT2, TRG20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BTT4
- Gene
- MED10
- Ensembl
- ENSG00000133398
- Chromosome
- 5
- Canonical length
- 135 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
MED10 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]
Canonical amino-acid sequenceUniProt
135 residues, UniProt reviewed canonical sequence.
>Q9BTT4|MED10
1 MAEKFDHLEE HLEKFVENIR QLGIIVSDFQ PSSQAGLNQK LNFIVTGLQD IDKCRQQLHD
61 ITVPLEVFEY IDQGRNPQLY TKECLERALA KNEQVKGKID TMKKFKSLLI QELSKVFPED
121 MAKYRSIRGE DHPPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MED10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 52 nTPM
- cerebral cortex: 42 nTPM
- hypothalamus: 40 nTPM
- hippocampal formation: 38 nTPM
- spinal cord: 38 nTPM
- amygdala: 38 nTPM
Single-cell type
- oocytes: 143 nCPM
- esophageal apical cells: 131 nCPM
- epididymal principal cells: 125 nCPM
- esophageal basal cells: 110 nCPM
- esophageal suprabasal cells: 105 nCPM
- breast lactating cells: 104 nCPM
Immune cell
- basophil: 128 nTPM
- total PBMC: 109 nTPM
- naive CD4 T-cell: 102 nTPM
- memory B-cell: 99 nTPM
- eosinophil: 95 nTPM
- memory CD4 T-cell: 94 nTPM
Brain region
- hypothalamus: 37 nTPM
- pons: 35 nTPM
- hippocampal formation: 32 nTPM
- white matter: 31 nTPM
- cerebral cortex: 30 nTPM
- midbrain: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 0.69
- DepMap mean gene effect
- -0.55
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of transcription elongation by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- protein ubiquitination
- RNA polymerase II preinitiation complex assembly
- somatic stem cell population maintenance
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Mediator complex, subunit Med10
- Transcription factor subunit Med10 of Mediator complex
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MED10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MED10 as an antibody target. Whether an autoantibody or antibody against MED10 could matter depends on whether native MED10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MED10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MED10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...